20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Disease outbreaks
Dataset Records for Disease outbreaks
Displaying 101 - 150 of 1018
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Mexico COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
Rural India COVID-19 Related Shocks Survey 2020 Round 3 (COVIDRS-R3)
COVID-19 Related Shocks in Rural India 2020, Round 3
Survey:
Household - Individual - Interview - Rural only
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: May 12, 2022
Ethiopia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Guinea COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey
GHDx Entry last modified on: Aug 1, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
India - Haryana Covid -19 Sero Survey Round 1, August 2020
Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study
Survey:
Epi surveillance
About 10 million people have been infected with the Corona virus in Afghanistan
حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State
Survey:
Epi surveillance
[Preliminary results of the National Health and Nutrition Survey COVID-19]
Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19
Survey:
Cross-sectional - Epi surveillance - Household - Individual - Nationally representative
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
Switzerland - Zurich SARS-CoV-2 Cohort: COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021
Survey:
Individual - Longitudinal
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
Cote d'Ivoire COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
Canada COVID-19 Seroprevalence in Ontario: July 4 to July 31, 2020
GHDx Entry last modified on: May 12, 2022
South Africa - Gauteng Province COVID-19 Status July 2020
GHDx Entry last modified on: Feb 10, 2022
Kuwait Hospital and ICU Admissions July 2020 - June 2021
No. of Hospital Admissions in Kuwait 3 July 2020- 3 June 2021 and No. of ICU Admissions in Kuwait 3 July 2020- 3 June 2021
Administrative data:
Health facility
Australia Notifications of COVID-19 by Age Group and Sex 2020-2021
Number of notifications of COVID-19*, Australia, by age group and sex
ORB General Population COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual - Nationally representative
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
COVID-19: 4,821 positive cases of coronavirus since the appearance of the pandemic in Equatorial Guinea
Covid 19: 4.821 casos positivos de coronavirus desde la aparición de la pandemia en Guinea Ecuatorial
Haiti COVID-19 Surveillance Bulletin 2020-2022
Bulletin de la surveillance du nouveau Coronavirus (COVID-19)
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: May 12, 2022
CDC COVID Data Tracker Nationwide Blood Donor Seroprevalence Survey 2021-2022
Survey:
Epi surveillance - Subnationally representative
Rural India COVID-19 Related Shocks Survey 2020 Round 2 (COVIDRS-R2)
COVID-19 Related Shocks in Rural India 2020, Round 2
Survey:
Household - Individual - Interview - Rural only
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Serbia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
Premise Child Health COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
Oman COVID-19 National Serological Survey Phase 1 2020
National Sero-Survey of COVID-19 Infection First Phase
Survey:
Cross-sectional - Epi surveillance
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It
GHDx Entry last modified on: Aug 1, 2022
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Third Quarter, July-September 2020
RCDC Surveillance Bullletin, 28-39 Weeks, Volume 23, 3rd Quarter 2020 (1st July to 30 September) 2020
Epi surveillance:
Subnationally representative
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje
Premise Women’s Health COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
Premise Malaria COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
Subscribe